Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing
Wolff Schmiegel, Rodney J Scott, Susan Dooley, Wendy Lewis, Cliff J Meldrum, Peter Pockney, Brian Draganic, Steve Smith, Chelsee Hewitt, Hazel Philimore, Amanda Lucas, Elva Shi, Kateh Namdarian, Timmy Chan, Danilo Acosta, Su Ping-Chang, Andrea Tannapfel, Anke Reinacher-Schick, Waldemar Uhl, Christian Teschendorf Show all
Molecular Oncology | WILEY | Published : 2017
Funding for the collection of samples in Australia was made possible by grants from the CSIRO, the Laby Foundation, and Therapeutic Innovation Australia. Financial support for this study in Germany was provided by a grant (PURE) from the Ministry of Science, North Rhine-Westphalia, Germany. This study was cooperatively funded by Sysmex Inostics and Merck KGaA. Drs Wolff Schmiegel and Rodney Scott are the guarantors of this work and, as such, had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.